Trimi vs JoinSkinny: Pricing, Shipping, and Care Compared
Quick verdict: Trimi vs JoinSkinny favors Trimi for lower starting cost on compounded semaglutide and a stated 6-month money-back promise, while JoinSkinny emphasizes flexible bundles, branded and compounded options, and 24/7 support.
Trimi vs JoinSkinny: what to compare first
This Trimi vs JoinSkinny comparison focuses on the clearest differences supported by the source evidence: pricing and plan structure, shipping and pharmacy handling, medication type and compounding status, medical oversight and support, and refund or cancellation terms. The introduction above gives an early verdict based only on the supplied facts.
1. Pricing and plan structure
Trimi lists compounded semaglutide from $99 per month on the annual plan and compounded tirzepatide at $125 per month, with flat pricing that does not rise as dose increases. Trimi advertises free overnight, temperature-controlled shipping and mentions a 6-month money-back promise for weight loss terms that apply.
JoinSkinny lists weight loss plans starting at $149, offers monthly and 3, 6, and 12 month bundles, and promotes a $140 promotional discount in the landing claims. JoinSkinny also states flat-rate dosing where monthly price stays the same regardless of dose and provides options to pay with Afterpay, Klarna, and Affirm. JoinSkinny highlights no monthly membership and the ability to cancel before the next billing cycle.
Compare Trimi membership details
2. Shipping speed and pharmacy handling
Trimi states free overnight, temperature-controlled shipping and that its medications are compounded by state-licensed 503A pharmacies including named partners, with a certificate of analysis available on request. JoinSkinny claims free temperature-controlled shipping that arrives in 1 to 2 days, same-day shipping for prescriptions received before 2 pm central time, and that prescriptions are filled by licensed, U.S.-based, FDA-regulated and LegitScript-certified pharmacy partners. Both providers include temperature management in their shipping claims.
3. Medication type and compounding notes
Trimi advertises compounded semaglutide and compounded tirzepatide and includes the regulatory note that compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality. Trimi explicitly describes medications as compounded and prepared per individual prescription.
JoinSkinny offers GLP-1 and GLP-1 + GIP options and says it works with licensed U.S. pharmacies that prepare authentic GLP-1 injections and GLP-1 + GIP when prescribed. JoinSkinny also includes the same regulatory note that compounded medications are not FDA-approved. JoinSkinny mentions branded prescriptions are filled and paid for separately in its captured pros and cons, indicating both compounded and branded workflows may apply depending on the prescription captured by the provider.
4. Medical oversight, support and eligibility
Trimi says its clinical oversight is provided by Arora Health, a network led by a board-certified physician licensed in all 50 states, and that licensed U.S. providers review and prescribe medications. Trimi mentions clinician review can reject approval and that if not approved by their medical team there is an automatic refund in some statements.
JoinSkinny describes care delivered by licensed U.S. providers, HIPAA protection, and ongoing monitoring with dose adjustments, monthly check-ins, and 24/7 chat support. JoinSkinny also states availability depends on state regulations and that entering your state during signup confirms eligibility.
Comparison table: Trimi vs JoinSkinny
| Criteria | Trimi | JoinSkinny |
|---|---|---|
| Starting price | Semaglutide from $99/mo on annual plan | Plans starting at $149; promotional discount noted |
| Plan types | Annual plan with flat pricing; membership covers meds and clinician visits | Monthly and 3, 6, 12 month bundles; no membership fee |
| Shipping | Free overnight, temperature-controlled shipping | Free temperature-controlled shipping; 1 to 2 day arrival, same-day processing before 2 pm CT |
| Pharmacy and compounding | Compounded meds from state-licensed 503A pharmacies; compounded meds not FDA-approved | Uses FDA-regulated, LegitScript-certified pharmacies; offers GLP-1 and GLP-1 + GIP, compounded or branded as described |
| Support and oversight | Licensed U.S. providers through Arora Health; clinician review and medical oversight | Licensed U.S. providers, monthly check-ins, dose guidance, and 24/7 chat |
| Refund or cancellation | 6-month money-back promise; automatic refund if not approved by medical team in some statements | Cancel anytime before next billing cycle; captured refund policy referenced |
5. Refunds, guarantees, and commitments
Trimi includes a 6-month money-back promise where you can request a refund if you do not lose weight after following the plan for 6 months, with terms that apply. Trimi also notes automatic refunds if not approved by their medical team in the captured landing evidence.
JoinSkinny includes a captured refund policy and emphasizes cancel anytime before your next billing cycle. Specifics of JoinSkinny refund terms were not supplied beyond the captured statements about cancellation and a refund policy.
View JoinSkinny plans and availability
Which should you choose?
Choose Trimi if you prioritize the lowest stated starting price for compounded semaglutide on an annual plan, overnight temperature-controlled shipping, named 503A compounding pharmacies, and a 6-month money-back promise as described in the source.
Choose JoinSkinny if you prefer flexible monthly or multi-month bundles, no membership fee, same-day processing for prescriptions received before 2 pm central time, and ongoing support with monthly check-ins and 24/7 chat as stated in the source.
Check JoinSkinny eligibility now
Both services state you should confirm eligibility, state availability, medication type, total cost, and renewal terms before enrolling. This comparison used only the supplied source evidence for Trimi vs JoinSkinny and preserved the qualifiers and regulatory notes provided.